CCM

Camber Capital Management Portfolio holdings

AUM $718M
1-Year Return 4.23%
This Quarter Return
+0.51%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$1.9B
AUM Growth
+$148M
Cap. Flow
+$161M
Cap. Flow %
8.49%
Top 10 Hldgs %
63.78%
Holding
40
New
10
Increased
11
Reduced
7
Closed
5

Sector Composition

1 Healthcare 82.31%
2 Technology 11.48%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ATRA icon
26
Atara Biotherapeutics
ATRA
$90.7M
$18.1M 0.96%
56,000
GSK icon
27
GSK
GSK
$81.5B
$16.9M 0.89%
360,000
-2,040,000
-85% -$96M
IMVT icon
28
Immunovant
IMVT
$2.99B
$15.4M 0.81%
438,800
-361,200
-45% -$12.7M
DRNA
29
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$9.45M 0.5%
+525,000
New +$9.45M
CBIO
30
Crescent Biopharma, Inc. Common Stock
CBIO
$198M
$7.68M 0.4%
25,000
-5,000
-17% -$1.54M
STRO icon
31
Sutro Biopharma
STRO
$89.9M
$6.03M 0.32%
600,000
GBT
32
DELISTED
Global Blood Therapeutics, Inc.
GBT
$2.76M 0.15%
+50,000
New +$2.76M
VIR icon
33
Vir Biotechnology
VIR
$732M
$565K 0.03%
+16,464
New +$565K
ANGO icon
34
AngioDynamics
ANGO
$436M
$252K 0.01%
+20,876
New +$252K
ASND icon
35
Ascendis Pharma
ASND
$12.5B
-350,000
Closed -$51.8M
TBIO
36
DELISTED
Translate Bio, Inc. Common Stock
TBIO
-1,000,000
Closed -$17.9M
MNTA
37
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
-450,000
Closed -$15M
GKOS icon
38
Glaukos
GKOS
$5.39B
-730,000
Closed -$28M
SAGE
39
DELISTED
Sage Therapeutics
SAGE
-525,000
Closed -$21.8M